# Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)

> **NCT00973102** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Hemorrhagic Shock

## Interventions

- **DRUG:** Premarin IV
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00973102
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973102, "Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00973102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*